BJSM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

Br J Sports Med. Published Online First: 15 July 2008. doi:10.1136/bjsm.2008.049742
Copyright © 2008 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine

This Article
Right arrow Full Text (Rapid PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Hew-Butler, T. D
Right arrow Articles by Verbalis, J. G
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hew-Butler, T. D
Right arrow Articles by Verbalis, J. G

Paper

Changes in plasma arginine vasopressin concentrations in cyclists participating in a 109 km cycle race

Tamara D Hew-Butler 1*, Jonathan P Dugas 2, Timothy D Noakes 3 and Joseph G Verbalis 4

1 Systemic Inflammation Lab, United States
2 University of Illinois at Chicago, United States
3 University of Cape Town, South Africa
4 Georgetown University Medical Center, United States

* To whom correspondence should be addressed. E-mail: tamara.hew{at}chw.edu.

Accepted 1 July 2008


*   Abstract

Objective: To evaluate the osmotic and non-osmotic regulation of arginine vasopressin (AVP) during endurance cycling

Design: observational study

Setting: 109 km cycle race

Participants: 33 cyclists

Interventions: none

Main Outcome Measurements: plasma sodium concentration ([Na+]), plasma volume (PV) and plasma AVP concentration ([AVP]p)

Results: A 4-fold increase in [AVP]p occurred despite a 2 mmol/L decrease in plasma [Na+] combined with only modest (5%) plasma volume contraction. A significant inverse correlation was noted between [AVP]p Ä versus urine osmolality Ä (r=-0.41; p<0.05) while non-significant inverse correlations were noted between [AVP]p versus both plasma [Na+] Ä and % PV Ä. Four cyclists finished the race with asymptomatic hyponatraemia. The only significant difference between the entire cohort with this subset of athletes was post-race plasma [Na+] (137.7 vs. 133.5 mmol/L; p<0.001) and plasma [Na+] Ä (-1.9 vs. -5.1 mmol/L; p<0.05). The mean pre-race [AVP]p of these four cyclists was just below the minimum detectable limit (0.3 pg/mL) and increased marginally (0.4 pg/mL) despite the decline in plasma [Na+].

Conclusions: Non-osmotic AVP secretion overshadowed the osmotic regulation of [AVP]p during competitive cycling. The modest decrease in plasma volume was not the primary non-osmotic stimulus to AVP. Partial suppression of AVP occurred in four (12%) cyclists who developed hyponatraemia during five hours of riding. Therefore, these results confirm that non-osmotic AVP secretion and EAH does, in fact, occur in cyclists participating in a 109 km cycle race. However, the stimuli to AVP is likely different between cycling versus running.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine